Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SGMO | CDXC | FHTX | ||
| Company | Sangamo Therapeutics | Chromadex Corp CS | Foghorn Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.50 | 6.98 | 9.24 | ||
| High | 2.97 | 7.03 | 9.53 | ||
| Low | 2.44 | 6.71 | 8.84 | ||
| Last | 2.81 | 6.77 | 9.11 | ||
| Change | +0.34 | -0.22 | -0.13 | ||
| % Change | +13.77% | -3.15% | -1.41% | ||
| Volume | 15,365,301 | 993,500 | 163,700 | ||
| 20-Day Average Volume | 13,631,605 | 2,538,850 | 125,475 | ||
| Previous Close | 2.47 | 6.99 | 9.24 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.55 | 4.20 | 7.99 | ||
| 20-Day Raw Stochastic | 92.59% | 91.84% | 82.87% | ||
| 20-Day Relative Strength | 78.50% | 79.93% | 58.19% | ||
| Weighted Alpha | +25.16 | +153.74 | +41.48 | ||
| Today's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 40% Buy | 56% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +65.29% since 10/31/24 | +93.98% since 10/31/24 | +19.55% since 10/31/24 | ||
| Low | 1.72 on 11/05/24 | 3.83 on 11/01/24 | 7.75 on 11/01/24 | ||
| High | 2.97 on 11/07/24 | 7.08 on 11/06/24 | 9.54 on 11/06/24 | ||
| 1-Month | |||||
| %Chg | +250.29% since 10/07/24 | +103.92% since 10/07/24 | +17.10% since 10/07/24 | ||
| Low | 0.77 on 10/10/24 | 3.18 on 10/10/24 | 6.94 on 10/10/24 | ||
| High | 2.97 on 11/07/24 | 7.08 on 11/06/24 | 9.54 on 11/06/24 | ||
| 3-Month | |||||
| %Chg | +227.93% since 08/07/24 | +157.41% since 08/07/24 | +80.75% since 08/07/24 | ||
| Low | 0.70 on 09/09/24 | 2.63 on 08/08/24 | 5.04 on 08/08/24 | ||
| High | 2.97 on 11/07/24 | 7.08 on 11/06/24 | 10.25 on 09/20/24 | ||
| 6-Month | |||||
| %Chg | +420.47% since 05/07/24 | +80.53% since 05/07/24 | +61.81% since 05/07/24 | ||
| Low | 0.30 on 07/05/24 | 2.31 on 06/26/24 | 4.77 on 07/10/24 | ||
| High | 2.97 on 11/07/24 | 7.08 on 11/06/24 | 10.25 on 09/20/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 514,306 | 533,917 | 513,679 | ||
| Shares Outstanding, K | 208,221 | 76,383 | 55,593 | ||
| Annual Sales | 176,230,000 | 83,570,000 | 34,160,000 | ||
| Annual Net Income | -257,830,000 | -4,940,000 | -98,430,000 | ||
| Last Quarter Sales | 360,000 | 25,580,000 | 6,890,000 | ||
| Last Quarter Net Income | -36,130,000 | 1,880,000 | -22,980,000 | ||
| 60-Month Beta | 1.10 | 1.88 | 3.14 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.17 on 08/06/24 | 0.02 on 10/31/24 | -0.31 on 11/04/24 | ||
| Latest Earnings Date | 11/12/24 | 10/31/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 611.00 | 0.00 | ||